Moolec Science Granted Conditional Nasdaq Listing Extension

summarizeSummary

Moolec Science SA announced that Nasdaq has granted its request for continued listing, subject to specific conditions and deadlines, providing a path to regain full compliance.

check_boxKey Events

• Continued Listing Granted

  The Nasdaq Hearings Panel has granted Moolec Science SA's request for continued listing on The Nasdaq Stock Market, averting an immediate delisting.

• Conditional Approval with Deadlines

  The continued listing is subject to specific conditions, including providing updates on derecognition proceedings by the end of February 2026 and updated pro forma financial information by the end of March 2026.

• Full Compliance Required by May 2026

  Moolec Science SA must demonstrate compliance with all Nasdaq Capital Market continued listing requirements on or before May 13, 2026.

• Bid Price Compliance Acknowledged

  The Panel acknowledged the company satisfied the minimum bid price requirement following its 15-for-1 reverse stock split on January 5, 2026, and will retain jurisdiction over this matter through May 13, 2026.

auto_awesomeAnalysis

This filing provides a critical update on Moolec Science SA's Nasdaq listing status, following previous disclosures regarding compliance issues. The company has successfully secured continued listing, averting an immediate delisting threat that was highlighted in the 6-K filed on January 22, 2026. However, this extension is conditional, requiring Moolec to provide updates on derecognition proceedings (a topic from the January 26, 2026 6-K), submit updated financial information, and demonstrate full compliance with all Nasdaq listing requirements by May 13, 2026. The Panel will also retain jurisdiction over the bid price matter, which was addressed by the reverse stock split on January 6, 2026. This conditional approval provides a clear, albeit challenging, roadmap for the company to maintain its public listing, which is crucial for a micro-cap entity.